STAAR Surgical Company
Lake Forest, CA, United States
Company overview
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
InvestorStack coverage
Latest articles
Market News
STAAR Surgical Posts 111% Revenue Surge in Q2 2026, Fueled by China EVO Plus Demand
STAAR Surgical reported Q2 2026 revenue of $93.54M, up 111% year over year, beating estimates as EVO Plus demand in China and global market share gains drove results.
Market News
Balance Sheet Analysis: How Cash Position Reveals Hidden Investment Risks and Opportunities
Analysis of three cash-rich companies reveals how balance sheet strength doesn't always indicate investment quality, with regional bank outperforming transportation and medical device peers.